Altitude Accelerator client Mirexus closes investment with GreenSky Accelerator Fund

GreenSky Accelerator Fund makes investment in Mirexus Biotechnologies Inc. GreenSky Principal Greg Stewart named Chairman of Mirexus Board Toronto, ON – October 8, 2015 The GreenSky Accelerator Fund I, LP (“the Fund”) is excited to announce that it has closed an investment with Mirexus Biotechnologies Inc. The Fund participated in the $4.5M syndicate alongside Barbados-based… Continue reading Altitude Accelerator client Mirexus closes investment with GreenSky Accelerator Fund

Cyclica Inc: Big Data, Better Medicine

By: Dana Bibi Wouldn’t it be great to eliminate costly trial and error experiments by having access to accurate trends and predictions? In the world of medicine, expensive pharmaceutical clinical trials impede the development of better and safer drugs. By compiling biological and chemical databases, Cyclica aims to streamline the research and development of medicines… Continue reading Cyclica Inc: Big Data, Better Medicine

OBIO: New program to bridge funding gap for life sciences companies gets financial boost from Ontario

TORONTO (June 3, 2013) – An industry-led program in Ontario that works to improve access to capital for human health technology and bioscience companies has received a major financial boost from the province of Ontario. The Ontario Ministry of Research and Innovation is providing funding to support the Capital Access Advisory Program (CAAP), a new… Continue reading OBIO: New program to bridge funding gap for life sciences companies gets financial boost from Ontario

Development and Manufacturing Challenges for Biologics – MaRS Future of Medicine Series

Seminar: Part of the MaRS Future of Medicine™ Series Topic: Development and Manufacturing Challenges for Biologics When: February 13, 2013 12:00 pm to 1:00 pm Where: MaRS Centre, Studio (Lower Concourse) 101 College Street Toronto, ON Come learn about the stages of drug development from someone who has seen it all. As a contract development… Continue reading Development and Manufacturing Challenges for Biologics – MaRS Future of Medicine Series

Challenges to Innovate in the Canadian Biotech Industry

By: Fatema Fatakdawala One of the key challenges faced by innovators of the R&D department is to develop economic value for their products in the pipeline. With the added burden of increasing regulatory hurdles, today, pharma and biotech companies have to waste up to an extra 2 years to get clearance from organizations such as… Continue reading Challenges to Innovate in the Canadian Biotech Industry

Sanofi Pasteur Healthcare & Biotech Venture Challenge 2012

Do you have an innovative product or service technology for the Healthcare, Biotech, or Life Sciences sector? Would you like some help and guidance at evaluating the commercial potential of your technology? Would you like to get some exposure for your product? Would you like to compete for cash prizes? Sanofi Pasteur Healthcare & Biotechnology… Continue reading Sanofi Pasteur Healthcare & Biotech Venture Challenge 2012

Are you a biotech start-up? Experience BIO 2012

By: Fatema Fatakdawala I recently had the opportunity to represent the Altitude Accelerator at the 2012 BIO International Convention in Boston Massachusetts. It was definitely the global biotechnology event of the year for me with over 4000 companies and a football stadium-sized exhibitor hall. Upstairs, there were multiple seminars, panel discussions and 15-minute business pitches… Continue reading Are you a biotech start-up? Experience BIO 2012

Commercializing Biotech to Fight Cancer

By: Fatema Fatakdawala The Altitude Accelerator is the Peel region’s portal to commercialization of research projects. When it comes to biotech start-ups with therapeutic products, it is now common knowledge that the “research“ phase can take decades to complete. As if going through three phases of clinical trials is not enough, these companies then have… Continue reading Commercializing Biotech to Fight Cancer

Betting on Biotech’s Global Impact

Monday, February 27, 2012 By: TIM KILADZE Ann Hanham: ‘Every company that this firm will invest in will go global from day one’ Too many Canadian startups are starved for money. Ann Hanham wants to change that. As a Canadian in Silicon Valley, venture capitalist Ann Hanham has done it all. Her distinguished résumé includes… Continue reading Betting on Biotech’s Global Impact

Patent filing is back on the rise – WIPO publishes two valuable reports

By James Taylor Two reports published by the World Intellectual Property Office (WIPO) demonstrate that patent filing is back on the rise and is of increasing value to stakeholders. This is interesting news for biotech startups and other companies who’s value is often determined by their cutting edge intellectual property. Each year, WIPO publishes an… Continue reading Patent filing is back on the rise – WIPO publishes two valuable reports